To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3571 | Nbd-10007 |
Novel HIV-1 entry inhibitor
More description
|
|
| DCC3570 | Nbd-09027 |
Novel HIV-1 entry inhibitor
More description
|
|
| DCC3569 | Nb-caged Tyrosine Hydrochloride |
L-Tyrosine caged with photosensitive ortho-nitrobenzyl side chain
More description
|
|
| DCC3568 | Nb-360 |
Biological Active Reagents
More description
|
|
| DCC3567 | Naxifylline |
Potent and selective A1 adenosine receptor antagonist
More description
|
|
| DCC3566 | Naveglitazar |
Dual peroxisome proliferator-activated receptor gamma and alpha (PPARgamma and PPARalpha) agonist
More description
|
|
| DCC3565 | Navarixin |
Novel CXC chemokine receptor 2 (CXCR2) antagonist
More description
|
|
| DCC3564 | Nav1.7 Blocker-801 |
Potent NaV1.7 blocker, being 5-10 fold more potent than NaV 1.2 and NaV 1.6
More description
|
|
| DCC3563 | Nav1.7 Blocker-24 |
Potent and selective blocker of voltage-gated Nav1.7 sodium channels
More description
|
|
| DCC3562 | Nav1.7 Blocker-13 |
Novel selective blocker of NaV1.7 with little affinity for NaV 1.2, 1.3, or 1.6, being more potent at human vs guinea pig NaV1.7
More description
|
|
| DCC3561 | Nav1.1-in-b |
Novel selective NaV1.1 inhibitor, reducing visceral hypersensitivity
More description
|
|
| DCC3560 | Tylophorine |
Potent suppressor of inducible nitric oxide synthase (iNOS; NOS II)
More description
|
|
| DCC3559 | Nargenicin |
Natural DnaE1 blocker, inducing a DNA damage response in Mycobacterium tuberculosis (Mtb) and inhibiting growth by blocking the replicative DNA polymerase, DnaE1
More description
|
|
| DCC3558 | N-arachidonoyl Taurine |
Activator of the transient receptor potential vanilloid (TRPV) channels TRPV1 and TRPV4
More description
|
|
| DCC3557 | Napsagatran |
Inhibitor of extrinsic and intrinsic thrombin generation, inhibiting clot-bound and free (fluid-phase thrombin)
More description
|
|
| DCC3556 | Napitane Mesylate |
Antagonist of alpha-2 adrenergic receptors and inhibitor of the neuronal uptake of norepinephrine
More description
|
|
| DCC3555 | Napi2b Inhibitor 15 |
Novel Gut-Restricted Inhibitor of Intestinal Sodium-Dependent Phosphate Transport Protein 2b (NaPi2b) for the Treatment of Hyperphosphatemia
More description
|
|
| DCC3554 | Naphyrone Hydrochloride |
Triple reuptake inhibitor
More description
|
|
| DCC3553 | Naphthyridine-azaquinolone |
Novel repeat-structure-specific DNA ligand, specifically binding slipped-CAG DNA intermediates of expansion mutations
More description
|
|
| DCC3552 | Naph-o2 |
Novel fluorescent probe for detection of endogenously produced Naph-O2˙– in living cells and tissues
More description
|
|
| DCC3551 | Nalbuphine Hydrochloride |
Mixed agonist/antagonist opioid modulator, binding with high affinity to the MOR and KOR, and having relatively low affinity for the DOR
More description
|
|
| DCC3550 | Nai003 |
Novel highly selective antibacterial agent against Propionibacterium acnes
More description
|
|
| DCC3549 | Nag-26 |
Novel potent full agonist for orexin receptor
More description
|
|
| DCC3548 | Nafoxidine |
Partial estrogen antagonist, inhibiting angiogenesis in some tissues by blocking the effects of fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF), inducing oxidative stress, protein kinase C and calcium signaling
More description
|
|
| DCC3547 | Nadph Tetrasodium Salt |
Electron donor and cofactor for many redox enzymes including nitric oxide synthetase
More description
|
|
| DCC3546 | Nadide |
Coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage
More description
|
|
| DCC3545 | N-adamantanylglycinamide Hbr |
Novel antiviral agent against the replication of influenza virus A/H3N2 subtype in Madin-Darby canine kidney (MDCK) cells
More description
|
|
| DCC3544 | N-acetylloline |
Derivative of loline
More description
|
|
| DCC3543 | Nabiximols |
Delta-9-tetrahydrocannabinol (THC)/cannabidiol (CBD) combination for the treatment of multiple sclerosis (MS)-related moderate to severe spasticity
More description
|
|
| DCC3542 | Na-aaf |
Alkylating agent, forming DNA adducts at the C-8 position in guanine, resulting in single strand breaks, demonstrating carcinogenic action
More description
|
|